Thomas P. Johnston, Ph.D., R.Ph.
UMKC School of Pharmacy
2464 Charlotte Street
Kansas City, MO 64108
An active area of research in the Johnston laboratory consists of the delivery of biologically-active small peptide drugs via the paracellular route following oral dosing. On a totally different front, we have developed a mouse model of dyslipidemia and atherosclerosis and are presently determining convenient biomarkers (oxidized-LDL-cholesterol, cell adhesion molecules, PPARs, “dysfunctional” HDL-cholesterol, etc.) that may be used to predict patients at risk for future coronary artery disease.